CCNG2 Overexpression Mediated by AKT Inhibits Tumor Cell Proliferation in Human Astrocytoma Cells

The cyclin family protein CCNG2 has an important inhibitory role in cancer initiation and progression, but the exact mechanism is still unknown. In this study, we examined the relationship between CCNG2 and the malignancy of astrocytomas and whether the AKT pathway, which is upregulated in astrocyto...

Full description

Bibliographic Details
Main Authors: Danfeng Zhang, Chunhui Wang, Zhenxing Li, Yiming Li, Dawei Dai, Kaiwei Han, Liquan Lv, Yicheng Lu, Lijun Hou, Junyu Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-04-01
Series:Frontiers in Neurology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fneur.2018.00255/full
_version_ 1811322586736361472
author Danfeng Zhang
Chunhui Wang
Zhenxing Li
Yiming Li
Dawei Dai
Kaiwei Han
Liquan Lv
Yicheng Lu
Lijun Hou
Junyu Wang
author_facet Danfeng Zhang
Chunhui Wang
Zhenxing Li
Yiming Li
Dawei Dai
Kaiwei Han
Liquan Lv
Yicheng Lu
Lijun Hou
Junyu Wang
author_sort Danfeng Zhang
collection DOAJ
description The cyclin family protein CCNG2 has an important inhibitory role in cancer initiation and progression, but the exact mechanism is still unknown. In this study, we examined the relationship between CCNG2 and the malignancy of astrocytomas and whether the AKT pathway, which is upregulated in astrocytomas, may inhibit CCNG2 expression. CCNG2 expression was found to be negatively associated with the pathological grade and proliferative activity of astrocytomas, as the highest expression was found in control brain tissue (N = 31), whereas the lowest expression was in high-grade glioma tissue (N = 31). Additionally, CCNG2 overexpression in glioma cell lines, T98G and U251 inhibited proliferation and arrested cells in the G0/G1 phase. Moreover, CCNG2 overexpression could increase glioma cells apoptosis. In contrast, AKT activity increased in glioma cells that had low CCNG2 expression. Expression of CCNG2 was higher in cells treated with the AKT kinase inhibitor MK-2206 indicating that the presence of phosphorylated AKT may inhibit the expression of CCNG2. Inhibition of AKT also led to decreased colony formation in T98G and U251 cells and knocked down of CCNG2 reversed the result. Finally, overexpression of CCNG2 in glioma cells reduced tumor volume in a murine model. To conclude, low expression of CCNG2 correlated with the severity astrocytoma and CCNG2 overexpression could induce apoptosis and inhibit proliferation. Inhibition of AKT activity increased the expression of CCNG2. The present study highlights the regulatory consequences of CCNG2 expression and AKT activity in astrocytoma tumorigenesis and the potential use of CCNG2 in anticancer treatment.
first_indexed 2024-04-13T13:38:50Z
format Article
id doaj.art-29f0c918a9d9476d9628e4af1d31c340
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-13T13:38:50Z
publishDate 2018-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-29f0c918a9d9476d9628e4af1d31c3402022-12-22T02:44:42ZengFrontiers Media S.A.Frontiers in Neurology1664-22952018-04-01910.3389/fneur.2018.00255332091CCNG2 Overexpression Mediated by AKT Inhibits Tumor Cell Proliferation in Human Astrocytoma CellsDanfeng ZhangChunhui WangZhenxing LiYiming LiDawei DaiKaiwei HanLiquan LvYicheng LuLijun HouJunyu WangThe cyclin family protein CCNG2 has an important inhibitory role in cancer initiation and progression, but the exact mechanism is still unknown. In this study, we examined the relationship between CCNG2 and the malignancy of astrocytomas and whether the AKT pathway, which is upregulated in astrocytomas, may inhibit CCNG2 expression. CCNG2 expression was found to be negatively associated with the pathological grade and proliferative activity of astrocytomas, as the highest expression was found in control brain tissue (N = 31), whereas the lowest expression was in high-grade glioma tissue (N = 31). Additionally, CCNG2 overexpression in glioma cell lines, T98G and U251 inhibited proliferation and arrested cells in the G0/G1 phase. Moreover, CCNG2 overexpression could increase glioma cells apoptosis. In contrast, AKT activity increased in glioma cells that had low CCNG2 expression. Expression of CCNG2 was higher in cells treated with the AKT kinase inhibitor MK-2206 indicating that the presence of phosphorylated AKT may inhibit the expression of CCNG2. Inhibition of AKT also led to decreased colony formation in T98G and U251 cells and knocked down of CCNG2 reversed the result. Finally, overexpression of CCNG2 in glioma cells reduced tumor volume in a murine model. To conclude, low expression of CCNG2 correlated with the severity astrocytoma and CCNG2 overexpression could induce apoptosis and inhibit proliferation. Inhibition of AKT activity increased the expression of CCNG2. The present study highlights the regulatory consequences of CCNG2 expression and AKT activity in astrocytoma tumorigenesis and the potential use of CCNG2 in anticancer treatment.http://journal.frontiersin.org/article/10.3389/fneur.2018.00255/fullastrocytomaAKT pathwaycarcinogenesisCCNG2MK 2206
spellingShingle Danfeng Zhang
Chunhui Wang
Zhenxing Li
Yiming Li
Dawei Dai
Kaiwei Han
Liquan Lv
Yicheng Lu
Lijun Hou
Junyu Wang
CCNG2 Overexpression Mediated by AKT Inhibits Tumor Cell Proliferation in Human Astrocytoma Cells
Frontiers in Neurology
astrocytoma
AKT pathway
carcinogenesis
CCNG2
MK 2206
title CCNG2 Overexpression Mediated by AKT Inhibits Tumor Cell Proliferation in Human Astrocytoma Cells
title_full CCNG2 Overexpression Mediated by AKT Inhibits Tumor Cell Proliferation in Human Astrocytoma Cells
title_fullStr CCNG2 Overexpression Mediated by AKT Inhibits Tumor Cell Proliferation in Human Astrocytoma Cells
title_full_unstemmed CCNG2 Overexpression Mediated by AKT Inhibits Tumor Cell Proliferation in Human Astrocytoma Cells
title_short CCNG2 Overexpression Mediated by AKT Inhibits Tumor Cell Proliferation in Human Astrocytoma Cells
title_sort ccng2 overexpression mediated by akt inhibits tumor cell proliferation in human astrocytoma cells
topic astrocytoma
AKT pathway
carcinogenesis
CCNG2
MK 2206
url http://journal.frontiersin.org/article/10.3389/fneur.2018.00255/full
work_keys_str_mv AT danfengzhang ccng2overexpressionmediatedbyaktinhibitstumorcellproliferationinhumanastrocytomacells
AT chunhuiwang ccng2overexpressionmediatedbyaktinhibitstumorcellproliferationinhumanastrocytomacells
AT zhenxingli ccng2overexpressionmediatedbyaktinhibitstumorcellproliferationinhumanastrocytomacells
AT yimingli ccng2overexpressionmediatedbyaktinhibitstumorcellproliferationinhumanastrocytomacells
AT daweidai ccng2overexpressionmediatedbyaktinhibitstumorcellproliferationinhumanastrocytomacells
AT kaiweihan ccng2overexpressionmediatedbyaktinhibitstumorcellproliferationinhumanastrocytomacells
AT liquanlv ccng2overexpressionmediatedbyaktinhibitstumorcellproliferationinhumanastrocytomacells
AT yichenglu ccng2overexpressionmediatedbyaktinhibitstumorcellproliferationinhumanastrocytomacells
AT lijunhou ccng2overexpressionmediatedbyaktinhibitstumorcellproliferationinhumanastrocytomacells
AT junyuwang ccng2overexpressionmediatedbyaktinhibitstumorcellproliferationinhumanastrocytomacells